Heartland Bank & Trust Co Acquires 103 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Heartland Bank & Trust Co boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 3.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,737 shares of the medical equipment provider’s stock after acquiring an additional 103 shares during the period. Heartland Bank & Trust Co’s holdings in Intuitive Surgical were worth $923,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in ISRG. Atticus Wealth Management LLC boosted its stake in shares of Intuitive Surgical by 85.4% during the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 41 shares in the last quarter. OFI Invest Asset Management purchased a new position in Intuitive Surgical during the 3rd quarter valued at about $25,000. Headinvest LLC purchased a new position in Intuitive Surgical during the 3rd quarter valued at about $28,000. Stone House Investment Management LLC lifted its position in Intuitive Surgical by 100.0% during the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 50 shares during the period. Finally, Householder Group Estate & Retirement Specialist LLC purchased a new position in Intuitive Surgical during the 3rd quarter valued at about $30,000. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ISRG. Barclays lifted their price target on shares of Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research report on Thursday, January 25th. StockNews.com cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Mizuho lifted their target price on shares of Intuitive Surgical from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Thursday, January 25th. Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a report on Friday, January 19th. Finally, Truist Financial lifted their target price on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a report on Wednesday, January 24th. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $371.60.

Read Our Latest Research Report on ISRG

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 196 shares of the firm’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the transaction, the senior vice president now directly owns 1,842 shares of the company’s stock, valued at $736,800. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Intuitive Surgical news, SVP Mark Brosius sold 196 shares of the stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the transaction, the senior vice president now owns 1,842 shares in the company, valued at $736,800. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gary S. Guthart sold 24,325 shares of the stock in a transaction on Monday, January 29th. The shares were sold at an average price of $376.06, for a total transaction of $9,147,659.50. Following the transaction, the chief executive officer now owns 9,425 shares of the company’s stock, valued at approximately $3,544,365.50. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 248,418 shares of company stock valued at $95,927,097. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded up $4.15 during midday trading on Wednesday, reaching $386.51. The stock had a trading volume of 471,987 shares, compared to its average volume of 1,656,950. The stock has a 50-day moving average of $386.82 and a 200-day moving average of $335.66. The company has a market capitalization of $137.00 billion, a price-to-earnings ratio of 76.02, a price-to-earnings-growth ratio of 6.13 and a beta of 1.36. Intuitive Surgical, Inc. has a 12-month low of $252.04 and a 12-month high of $403.76.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last announced its quarterly earnings data on Tuesday, January 23rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.48 by $0.12. The firm had revenue of $1.93 billion during the quarter, compared to analysts’ expectations of $1.89 billion. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. The company’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.91 earnings per share. As a group, analysts forecast that Intuitive Surgical, Inc. will post 4.93 EPS for the current fiscal year.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.